Development of the renal glucose reabsorption inhibitors: a new mechanism for the pharmacotherapy of diabetes mellitus type 2.

Article Details

Citation

Washburn WN

Development of the renal glucose reabsorption inhibitors: a new mechanism for the pharmacotherapy of diabetes mellitus type 2.

J Med Chem. 2009 Apr 9;52(7):1785-94. doi: 10.1021/jm8013019.

PubMed ID
19243175 [ View in PubMed
]
Abstract

Not Available

DrugBank Data that Cites this Article

Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
DapagliflozinSodium/glucose cotransporter 2EC 50 (nM)1.1N/AN/ADetails